Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Mar;76(3):816-830.
doi: 10.1111/all.14687. Epub 2020 Dec 29.

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Emek Kocatürk  1 Andaç Salman  2 Ivan Cherrez-Ojeda  3 Paulo Ricardo Criado  4   5   6 Jonny Peter  7 Elif Comert-Ozer  2 Mohamed Abuzakouk  8 Rosana Câmara Agondi  9 Mona Al-Ahmad  10 Sabine Altrichter  11 Rand Arnaout  12 Luisa Karla Arruda  13 Riccardo Asero  14 Andrea Bauer  15 Moshe Ben-Shoshan  16 Jonathan A Bernstein  17 Mojca Bizjak  18 Isabelle Boccon-Gibod  19 Hanna Bonnekoh  20   21 Laurence Bouillet  19 Zenon Brzoza  22 Paula Busse  23 Regis A Campos  24   25 Emily Carne  26 Niall Conlon  27 Roberta F Criado  28 Eduardo M de Souza Lima  29 Semra Demir  30 Joachim Dissemond  31 Sibel Doğan Günaydın  32 Irina Dorofeeva  33 Luis Felipe Ensina  34 Ragıp Ertaş  35 Silvia Mariel Ferrucci  36 Ignasi Figueras-Nart  37 Daria Fomina  38   39 Sylvie M Franken  40 Atsushi Fukunaga  41 Ana M Giménez-Arnau  42 Kiran Godse  43 Margarida Gonçalo  44 Maia Gotua  45 Clive Grattan  46 Carole Guillet  47 Naoko Inomata  48 Thilo Jakob  49 Gul Karakaya  50 Alicja Kasperska-Zając  51 Constance H Katelaris  52 Mitja Košnik  18 Dorota Krasowska  53 Kanokvalai Kulthanan  54 M Sendhil Kumaran  55 Claudia Lang  47 José Ignacio Larco-Sousa  56 Elisavet Lazaridou  57 Tabi Anika Leslie  58 Undine Lippert  59 Oscar Calderón Llosa  60 Michael Makris  61 Alexander Marsland  62 Iris V Medina  63 Raisa Meshkova  64 Esther Bastos Palitot  65 Claudio A S Parisi  66 Julia Pickert  67 German D Ramon  68 Mónica Rodríguez-Gonzalez  69 Nelson Rosario  70 Michael Rudenko  71 Krzysztof Rutkowski  72 Jorge Sánchez  73 Sibylle Schliemann  74 Bulent Enis Sekerel  75 Faradiba S Serpa  76 Esther Serra-Baldrich  77 Zhiqiang Song  78 Angèle Soria  79 Maria Staevska  80 Petra Staubach  81 Anna Tagka  82 Shunsuke Takahagi  83 Simon Francis Thomsen  84 Regina Treudler  85 Zahava Vadasz  86 Solange Oliveira Rodrigues Valle  87 Martijn B A Van Doorn  88 Christian Vestergaard  89 Nicola Wagner  90 Dahu Wang  91 Liangchun Wang  92 Bettina Wedi  93 Paraskevi Xepapadaki  94 Esra Yücel  95 Anna Zalewska-Janowska  96 Zuotao Zhao  97 Torsten Zuberbier  21 Marcus Maurer  98
Affiliations
Multicenter Study

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Emek Kocatürk et al. Allergy. 2021 Mar.

Abstract

Introduction: The COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown.

Aim: To understand how CU patients are affected by the COVID-19 pandemic; how specialists alter CU patient management; and the course of CU in patients with COVID-19.

Materials and methods: Our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed the impact of the pandemic on patient consultations, remote treatment, changes in medications, and clinical consequences.

Results: The COVID-19 pandemic severely impairs CU patient care, with less than 50% of the weekly numbers of patients treated as compared to before the pandemic. Reduced patient referrals and clinic hours were the major reasons. Almost half of responding UCARE physicians were involved in COVID-19 patient care, which negatively impacted on the care of urticaria patients. The rate of face-to-face consultations decreased by 62%, from 90% to less than half, whereas the rate of remote consultations increased by more than 600%, from one in 10 to more than two thirds. Cyclosporine and systemic corticosteroids, but not antihistamines or omalizumab, are used less during the pandemic. CU does not affect the course of COVID-19, but COVID-19 results in CU exacerbation in one of three patients, with higher rates in patients with severe COVID-19.

Conclusions: The COVID-19 pandemic brings major changes and challenges for CU patients and their physicians. The long-term consequences of these changes, especially the increased use of remote consultations, require careful evaluation.

Keywords: COVID-19; SARS-CoV-2; UCARE; chronic urticaria; cyclosporine; omalizumab; pandemic; treatment.

PubMed Disclaimer

References

REFERENCES

    1. Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy 2020;75(2):423-432. https://doi.org/10.1111/all.14037
    1. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018;73(7):1393-1414. https://doi.org/10.1111/all.13397
    1. Guillén-Aguinaga S, Jáuregui Presa I, Aguinaga-Ontoso E, Guillén-Grima F, Ferrer M. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: A systematic review and meta-analysis. Br J Dermatol. 2016;175:1153-1165.
    1. Kocatürk E, Can PK, Akbas PE, et al. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study. J Dermatol Sci. 2017;87(1):60-69. https://doi.org/10.1016/j.jdermsci.2017.02.283
    1. Maurer M, Costa C, Gimenez Arnau A, et al. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin Exp Allergy 2020;50(10):1166-1175. [published online ahead of print, 2020 Jul 31]. Clin Exp Allergy. 2020;10.1111/cea.13716. doi:10.1111/cea.13716.

Publication types

LinkOut - more resources